Breast Cancer: Role of Imaging

  • Harnoor Singh


Breast cancer is one of the most prevalent cancers in women; about one in eight women will be affected by it. Also, it is one of the leading causes of death in women. It is critical to get involved in breast screening to enable early detection with consequent decreased morbidity and mortality associated with breast cancer.

Screening mammography is estimated to reduce breast cancer mortality by almost 40% if performed on an annual basis rather than less frequently. Screening for breast cancer can also involve ultrasound and MRI depending on the age and individualized risk for a patient.

Imaging for breast cancer involves screening as well as diagnostic modalities. BI-RADS (breast imaging-reporting and data system) categories are used to categorize breast imaging reports. The diagnosis of breast cancer is established with the use of image-guided biopsies involving ultrasound, stereotactic guidance, and MRI. These also play a critical role in treatment planning and monitoring.

The following discussion will elaborate on the different imaging modalities used for the screening and diagnosis of breast cancer.


Breast cancer screening Risk factors for breast cancer Functional unit of the breast Ultrasound MRI BI-RADS TNM staging 


  1. 1.
    Lee SC, Jain PA, Jethwa SC, Tripathy D, Yamashita MW. Radiologist’s role in breast cancer staging: providing key information for clinicians. Radiographics. 2014;34(2):330–42.CrossRefGoogle Scholar
  2. 2.
    Chen L, Chantra PK, Larsen LH, Barton P, Rohitopakarn M, Zhu EQ, et al. Imaging characteristics of malignant lesions of the male breast. Radiographics. 2006;26(4):993–1006.CrossRefGoogle Scholar
  3. 3.
    Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(Suppl 1):14–25.CrossRefGoogle Scholar
  4. 4.
    Chen W. Patient education: factors that modify breast cancer risk in women (beyond the basics).
  5. 5.
    Nicholson BT, Harvey JA, Cohen MA. Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics. 2009;29(2):509–23.CrossRefGoogle Scholar
  6. 6.
    American College of Radiology. Benefits and limitations of mammography. Digest of Council Action 2015-2016: 2002, amended 2012 (Res. 23-c).Google Scholar
  7. 7.
    Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 2014;106(11)Google Scholar
  8. 8.
    Helquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, et al. Effectiveness of population-based service screening with mammography for women ages 40-49 years. Cancer. 2010;117(4):714–22.CrossRefGoogle Scholar
  9. 9.
    Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era. Cancer. 2014;120(17):2649–56.CrossRefGoogle Scholar
  10. 10.
    Koroukian SM, Bakaki PM, Htoo PT, Han X, Schluchter M, Owusu C, et al. The breast and cervical cancer early detection program, medicaid, and breast cancer outcomes among Ohio’s underserved women. Cancer. 2017;123(16):3097–106.CrossRefGoogle Scholar
  11. 11.
    Hendrick RE, Helvie MA. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. AJR Am J Roentgenol. 2012;198:723–8.CrossRefGoogle Scholar
  12. 12.
    Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2014., based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017.
  13. 13.
    Grady D, Redberg R. Physician adherence to breast cancer screening recommendations. JAMA Intern Med. 2017;177(6):763–4.CrossRefGoogle Scholar
  14. 14.
    Berg W, Mendelson EB, Merritt CB. ACRIN 6666: screening breast ultrasound in high risk women.
  15. 15.
    Kennedy DA, Lee T, Seely D. A comparative review of thermography as a breast cancer screening technique. Integr Cancer Ther. 2009;8(1):9–16.CrossRefGoogle Scholar
  16. 16.
    Gautherie M. Thermobiological assessment of benign and malignant breast diseases. Am J Obstet Gynecol. 1983;147(8):861–9.CrossRefGoogle Scholar
  17. 17.
    Alcantara D, Leal MP, Garcia-Bocanegra I, Garcia-Martin ML. Molecular imaging of breast cancer: present and future directions. Front Chem. 2014;2:112.CrossRefGoogle Scholar
  18. 18.
    O’Connor MK. Molecular breast imaging: an emerging modality for breast cancer screening. Breast Cancer Manag. 2015;4(1):33–40.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Harnoor Singh
    • 1
  1. 1.Department of RadiologyTexas OncologyAmarilloUSA

Personalised recommendations